Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, Johnson G, Bauer
M, Williams HM, Kaplan KM, Guess HA, Oxman MN: Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain
inventory. J Pain. 5(6): 344-56, August 2004.
Coplan PM, Cook JR, Carides GW, Heyse JF, Wu AW, Hammer SM, Nguyen BY,
Meibohm AR, DiNubile MJ; AIDS Clinical Trials Group 320 Study Team: Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Clin Infect Dis. 39(3): 426-33 (Epub July 19, 2004), August 1 2004.
Coplan PM, Mitchnick M, Rosenberg ZF: Public health. Regulatory challenges in microbicide development. Science 304(5679): 1911-2, June 25 2004.
Rojas C, Coplan PM, Rhodes T, Robertson MN, DiNubile MJ, Guess HA: Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trials. Pharmacoepidemiol Drug Saf. 12(5): 361-9, Jul-Aug 2003.
Coplan PM, Nikas A, Japour A, Cormier K, Maradit-Kremers H, Lewis R, Xu Y,
DiNubile MJ.: Incidence of myocardial infarction in randomized clinical trials of protease
inhibitor-based antiretroviral therapy: an analysis of four different protease
inhibitors. AIDS Res Hum Retroviruses. 19(6): 449-55, June 2003.
Fife KH, Coplan PM, Jansen KU, DiCello AC, Brown DR, Rojas C, Su L: Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men. Sex Transm Dis. 30(3): 246-8, March 2003.
Coplan PM, Nikas AA, Leavitt RY, Doll L, Nessly ML, DiNubile MJ, Guess HA.: Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials. AIDS 15(12): 1584-6, August 17 2001.
Clements DA, Zaref JI, Bland CL, Walter EB, Coplan PM. : Partial uptake of varicella vaccine and the epidemiological effect on varicella disease in 11 day-care centers in North Carolina. Arch Pediatr Adolesc Med. 155(4): 455-61, April 2001.
Markey P, Krause V, Boslego JW, Coplan PM, Dargan JM, Kaplan KM.: The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high-risk population measured using immunization register data. Epidemiol Infect. 126(1): 31-6, February 2001.
Pellissier JM, Coplan PM, Jackson LA, May JE: The effect of additional shots on the vaccine administration process: results of a time-motion study in 2 settings. Am J Manag Care. 6(9): 1038-44, September 2000.
back to top
Last updated: 10/07/2004
The Trustees of the University of Pennsylvania